Helping kids hear the future
Fennec Pharmaceuticals is a biotechnology company dedicated to improving the lives of children with cancer who experience hearing loss as a result of chemotherapy.
Latest News
- Fennec Pharmaceuticals Announces First Quarter 2023 Financial Results and Provides Business Update
- Fennec Pharmaceuticals to Report First Quarter 2023 Financial Results on May 11, 2023
- Fennec Pharmaceuticals Receives Positive CHMP Opinion for Pedmarqsi™ (sodium thiosulfate) to Reduce the Risk of Hearing Loss in Pediatric Oncology Patients